GLP-1 and Blindness

from KGNU - How On Earth · host KGNU - How On Earth

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. … Continue reading "GLP-1 and Blindness"

Episode metadata supplied by the publisher feed · Published Jun 10, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 and Blindness

0:00 26:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of KGNU - How On Earth?

This episode is 26 minutes long.

When was this KGNU - How On Earth episode published?

This episode was published on June 10, 2025.

Can I download this KGNU - How On Earth episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!